ID   HOSM-2
AC   CVCL_A2BJ
SY   Human OsteoSarcoma from Mandible-2
DR   cancercelllines; CVCL_A2BJ
DR   IARC_TP53; 20215
DR   Wikidata; Q105507713
RX   CelloPub=CLPUB00596;
RX   PubMed=15172645;
RX   PubMed=19878029;
CC   Population: Japanese.
CC   Doubling time: 74.8 hours (CelloPub=CLPUB00596); 70.6 hours (PubMed=15172645).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Unspecified (PubMed=15172645).
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2BI ! HOSM-1
OI   CVCL_A2BK ! HOSMN-1C
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 05-10-23; Version: 5
//
RX   CelloPub=CLPUB00596;
RA   Tagawa T., Nomura J., Kihira H., Murata M.;
RT   "A new established osteosarcoma cell line from human mandible.";
RL   Mie Med. J. 39:279-286(1989).
//
RX   PubMed=15172645; DOI=10.1016/j.oraloncology.2004.01.015;
RA   Narita M., Nomura J., Nakase M., Inui M., Murata T., Hamaguchi Y.,
RA   Tagawa T.;
RT   "Characterization of the human mandibular osteoblastic osteosarcoma
RT   cell line HOSM-2 after long-term culture.";
RL   Oral Oncol. 40:742-750(2004).
//
RX   PubMed=19878029; DOI=10.1089/pho.2008.2329;
RA   Yanase S., Nomura J., Matsumura Y., Watanabe Y., Tagawa T.;
RT   "Synergistic increase in osteosarcoma cell sensitivity to photodynamic
RT   therapy with aminolevulinic acid hexyl ester in the presence of
RT   hyperthermia.";
RL   Photomed. Laser Surg. 27:791-797(2009).
//